Literature DB >> 11881726

Cancer fatigue.

C Fulton1, G Knowles.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11881726

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN： 0961-5423            Impact factor:   2.520


× No keyword cloud information.
  5 in total

1.  Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial.

Authors:  Amanda R Moraska; Amit Sood; Shaker R Dakhil; Jeff A Sloan; Debra Barton; Pamela J Atherton; Jason J Suh; Patricia C Griffin; David B Johnson; Aneela Ali; Peter T Silberstein; Steven F Duane; Charles L Loprinzi
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

2.  Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2.

Authors:  Debra L Barton; Heshan Liu; Shaker R Dakhil; Breanna Linquist; Jeff A Sloan; Craig R Nichols; Travis W McGinn; Philip J Stella; Grant R Seeger; Amit Sood; Charles L Loprinzi
Journal:  J Natl Cancer Inst       Date:  2013-07-13       Impact factor: 13.506

3.  Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA.

Authors:  Debra L Barton; Gamini S Soori; Brent A Bauer; Jeff A Sloan; Patricia A Johnson; Cesar Figueras; Steven Duane; Bassam Mattar; Heshan Liu; Pamela J Atherton; Bradley Christensen; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2009-05-06       Impact factor: 3.603

4.  Traditional Herbal Medicine, Sipjeondaebo-Tang, for Cancer-Related Fatigue: A Randomized, Placebo-Controlled, Preliminary Study.

Authors:  Jee Young Lee; Eun Hye Kim; Jee-Hyun Yoon; Wankyu Eo; Seong Woo Yoon
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

5.  Shenmai injection for the treatment of cancer-related fatigue in advanced non-small cell lung cancer patients undergoing chemotherapy: study protocol for a randomized controlled trial.

Authors:  Yushu Zhou; Baiming Zhao; Wanyin Wu; Xiaobing Yang; Shunqin Long; Hong Deng; Wenfeng He; Guiya Liao; Qiuping Li; Zhen Xie
Journal:  Trials       Date:  2018-09-04       Impact factor: 2.279
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.